Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis
Sponsored by United Therapeutics Corporation
Active
$207.1K Funding
5 People
External
Related Topics
pulmonary fibrosis,
inhaled therapeutics,
clinical trial,
drug efficacy,
safety assessment
People
Maria Gordon
(CD)
Az Health Sciences Division
﹒Clinical Research Manager II
Maria Ambrose
(CD)
Az Health Sciences Division
﹒Research Specialist, Senior
Kirsten Anderson
(CD)
Az Health Sciences Division
﹒Research Compliance Administrator IV
Austin Derma
(CD)
Az Health Sciences Division
﹒Clinical Research Coordinator II
Daniel Duran
(CD)
Az Health Sciences Division
﹒Clinical Research Coordinator I
